Vineti and World Courier partner to extend reach of cell and gene therapies

Digital traceability and orchestration solution for cell and gene therapies, Vineti, and specialist logistics company, World Courier, have partnered to further extend the reach of cell and gene therapies worldwide.

As a partnership, the companies will offer a holistic, integrated logistics and supply solution that will enable cell and gene therapy developers to scale their treatments, care networks and manufacturing both quickly and safely.

“We’re very pleased to be working with the deeply knowledgeable, experienced World Courier team,” said Amy DuRoss, CEO and co-founder of Vineti. “Together, Vineti and World Courier provide a powerful option that helps move innovative therapies into mainstream healthcare. Our shared expertise and solutions are well-positioned to help cell and gene therapies scale world-wide, whether they’re commercial-ready or clinical phase.”

Sam Herbert, president of World Courier, commented: “Offering Vineti’s digital platform of record bolsters the options available within our global logistics platform, offering a wider choice for cell and gene therapy developers to trace, orchestrate and scale their products. We’re pleased to be working together to realise the full potential of cell and gene therapies for both patients and manufacturers.”

The combined solution (Vineti-World Courier solution) will be offered through World Courier’s global network, as well as directly through Vineti’s business development team.